Titan Securities Ltd (530045)

Titan Securities approved its standalone and consolidated unaudited financial results for the quarter and half-year ended September 30, 2026. The auditor's review report noted that the consolidated results include the Group's share of net profit after tax of ₹502.32 lacs (₹5.02 crore) from associates Titan Biotech Limited and Peptech Biosciences Limited. The board meeting concluded within 30 minutes, and the statutory auditors issued an unmodified review report. However, the detailed financial tables were not included in the primary text extract.

• Share of net profit after tax from associates stood at ₹502.32 lacs for Q2 ended September 30, 2026
• Share of total comprehensive income from associates was ₹501.69 lacs for the quarter
• Auditor issued an unmodified limited review report for both standalone and consolidated financials
• Board meeting commenced at 17:00 IST and concluded at 17:30 IST on November 05, 2026

Titan Securities Limited concluded its 34th Annual General Meeting on September 29, 2026, conducted via video conference with 301 total members present. Ordinary business included adopting FY26 audited financial statements and re-appointing Director Naresh Kumar Singla. Key special business items commended for approval included borrowing powers, creation of charges/mortgages on company properties, and approval of material related party transactions. The company also noted proposed steps toward listing its securities with NSDL.

• Held 34th AGM on September 29, 2026, between 5:00 PM and 5:59 PM IST
• A total of 301 members attended the meeting (4 promoter/promoter group and 297 public via VC)
• Put forward special business resolutions for borrowing powers, creation of charges/mortgages, and material related-party transactions
• Noted plans to pursue steps toward listing securities with NSDL subject to regulatory approvals

Titan Securities has appointed Mr. Ranjeet Kumar as its Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) effective August 13, 2026. Mr. Kumar has over 15 years of experience in accounts, taxation, and financial management. This appointment comes as the company, a micro-cap NBFC with a market cap of ₹106 Cr, manages a unique financial profile where TTM PAT (₹12 Cr) significantly exceeds TTM Revenue (₹6 Cr). The transition is a routine regulatory requirement for filling key leadership roles.

• Appointment of Mr. Ranjeet Kumar as CFO effective from August 13, 2026
• New CFO brings over 15 years of professional experience in accounting and taxation
• Company maintains a high promoter holding of 73.95% as of June 2026
• TTM PAT stands at ₹12 Cr against a TTM Revenue of ₹6 Cr, indicating high non-operating income
• Mr. Kumar holds a B.Com (Honours) degree and has completed CA Intermediate

Titan Securities has appointed Mr. Ranjeet Kumar as Chief Financial Officer (CFO) effective August 13, 2026, following a board meeting to approve Q1 FY27 results. The company reported a consolidated net profit share from its associates, Titan Biotech and Peptech Biosciences, amounting to ₹4.56 Cr for the quarter ended June 30, 2026. This quarterly profit share is highly significant, representing approximately 76% of the company's total TTM revenue of ₹6 Cr. Mr. Kumar brings over 15 years of experience in accounts and taxation to the leadership team.

• Appointment of Mr. Ranjeet Kumar as CFO (KMP) effective August 13, 2026.
• Group share of net profit from associates stood at ₹456.46 lacs (₹4.56 Cr) for Q1 FY27.
• New CFO has 15+ years of experience and is a CA Intermediate with a B.Com (Hons) degree.
• Consolidated results include performance from associates Titan Biotech Limited and Peptech Biosciences Limited.
• The board meeting was brief, commencing at 5:00 P.M. and concluding at 5:30 P.M.

Titan Securities has scheduled a board meeting for August 13, 2026, to approve its unaudited financial results for the quarter ended June 30, 2026. This micro-cap NBFC (Market Cap: Rs 105 Cr) has a unique financial profile where TTM PAT of Rs 12 Cr significantly exceeds its TTM Revenue of Rs 6 Cr, suggesting heavy reliance on investment income or other non-operating gains. The trading window for insiders has been closed since June 23, 2026, and will remain so until 48 hours after the results are declared.

• Board meeting scheduled for August 13, 2026, to approve Q1 FY27 results
• Trading window for insiders has been closed since June 23, 2026
• Company reported a TTM PAT of Rs 12 Cr against a TTM Revenue of Rs 6 Cr
• Promoter holding remains stable at 73.95% as of June 2026